Literature DB >> 16343696

Tau protein abnormalities associated with the progression of alzheimer disease type dementia.

V Haroutunian1, P Davies, C Vianna, J D Buxbaum, D P Purohit.   

Abstract

The degree to which neurofibrillary tangles (NFT), the hallmark lesions of Alzheimer disease (AD), contribute to the development of the cognitive symptoms of AD has been debated. NFTs are comprised of abnormally phosphorylated and conformationally altered tau proteins. Conformational changes in tau have been proposed to be among the earliest neurobiological changes in AD. This study examined whether conformational changes detected by antibodies MC1 and TG3 represent early abnormalities in the disease process by assessing their presence at different stages of dementia in multiple brain regions. Postmortem specimens from several neocortical regions were examined for conformational changes in tau by ELISA in subjects [n=81] who died at different stages of cognitive impairment. Concentrations of conformationally altered tau increased with increasing dementia severity and the levels of MC1 immunoreactivity increased in the frontal cortex of mildly demented subjects before the appearance of NFT bearing neurons, suggesting that conformational alterations in tau occur early in the course of AD and its cognitive symptoms and may precede histologically identified NFTs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16343696     DOI: 10.1016/j.neurobiolaging.2005.11.001

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  39 in total

Review 1.  An update on treatment and prevention strategies for Alzheimer's disease.

Authors:  Judith Neugroschl; Mary Sano
Journal:  Curr Neurol Neurosci Rep       Date:  2009-09       Impact factor: 5.081

2.  Association of ApoE and LRP mRNA levels with dementia and AD neuropathology.

Authors:  Afia Akram; James Schmeidler; Pavel Katsel; Patrick R Hof; Vahram Haroutunian
Journal:  Neurobiol Aging       Date:  2011-06-15       Impact factor: 4.673

3.  Proteopathic tau seeding predicts tauopathy in vivo.

Authors:  Brandon B Holmes; Jennifer L Furman; Thomas E Mahan; Tritia R Yamasaki; Hilda Mirbaha; William C Eades; Larisa Belaygorod; Nigel J Cairns; David M Holtzman; Marc I Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-26       Impact factor: 11.205

4.  Synaptic actin stabilization protein loss in Down syndrome and Alzheimer disease.

Authors:  Julie C Lauterborn; Conor D Cox; See Wing Chan; Peter W Vanderklish; Gary Lynch; Christine M Gall
Journal:  Brain Pathol       Date:  2019-09-08       Impact factor: 6.508

5.  Alzheimer's disease imaging with a novel Tau targeted near infrared ratiometric probe.

Authors:  Hye-Yeong Kim; Urmi Sengupta; Pin Shao; Marcos J Guerrero-Muñoz; Rakez Kayed; Mingfeng Bai
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-03-08

6.  Increased expression of RXRα in dementia: an early harbinger for the cholesterol dyshomeostasis?

Authors:  Afia Akram; James Schmeidler; Pavel Katsel; Patrick R Hof; Vahram Haroutunian
Journal:  Mol Neurodegener       Date:  2010-09-15       Impact factor: 14.195

7.  PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia.

Authors:  Weiping Qin; Vahram Haroutunian; Pavel Katsel; Christopher P Cardozo; Lap Ho; Joseph D Buxbaum; Giulio M Pasinetti
Journal:  Arch Neurol       Date:  2009-03

Review 8.  Potential mechanisms and implications for the formation of tau oligomeric strains.

Authors:  Julia E Gerson; Amrit Mudher; Rakez Kayed
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-09-21       Impact factor: 8.250

9.  Ibuprofen reduces Abeta, hyperphosphorylated tau and memory deficits in Alzheimer mice.

Authors:  Ann C McKee; Isabel Carreras; Lokman Hossain; Hoon Ryu; William L Klein; Salvatore Oddo; Frank M LaFerla; Bruce G Jenkins; Neil W Kowall; Alpaslan Dedeoglu
Journal:  Brain Res       Date:  2008-02-16       Impact factor: 3.252

10.  Curcumin suppresses soluble tau dimers and corrects molecular chaperone, synaptic, and behavioral deficits in aged human tau transgenic mice.

Authors:  Qiu-Lan Ma; Xiaohong Zuo; Fusheng Yang; Oliver J Ubeda; Dana J Gant; Mher Alaverdyan; Edmond Teng; Shuxin Hu; Ping-Ping Chen; Panchanan Maiti; Bruce Teter; Greg M Cole; Sally A Frautschy
Journal:  J Biol Chem       Date:  2012-12-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.